Stock Market News2 weeks J&J’s Tremfya Gets FDA Nod for 2nd IBD Condition Crohn’s Disease Zacks
FDA approves J&J’s Tremfya for its fourth indication and the second IBD condition.
X1 hour US judge rejects J&J’s $10 billion baby powder settlement Investing.com
X7 hours Why Johnson & Johnson (JNJ), United Health (UNH) And Procter & Gamble (PG) Are Holding the S&P 500 From Dropping More 24/7 Wall St.
X1 day Procter & Gamble, Johnson & Johnson Among 10 Companies To Announce Dividend Increases In First Half Of April Seeking Alpha
X2 days Jim Cramer on Johnson & Johnson (NYSE:JNJ): Their Spinoff Was Ill-Advised Yahoo Finance
X3 days Johnson & Johnson Needs Time To Consolidate (Technical Analysis And Downgrade) Seeking Alpha
X3 days Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case Yahoo Finance
X4 days JNJ Elliott Wave technical analysis [Video] FXStreet
X1 week Johnson & Johnson (JNJ) Stock Dips While Market Gains: Key Facts Zacks
X1 week Here’s How to Play JNJ Stock as it Announces $55B US Investment Plan Zacks
X1 week J&J to Invest $55B in United States to Boost Manufacturing, R&D Zacks
X1 week Johnson & Johnson to invest $55 billion in U.S. 💰 #shorts YouTube
X1 week J&J boosts US operations with $55bn investment Yahoo Finance
X1 week Pharma Stock Roundup: PFE’s Final Haleon Stake Sale, AZN, SNY M&A Deals Zacks
X1 week J&J boosts US investments by 25% over 4 years amid looming tariff threats Investing.com
X1 week Johnson & Johnson to Invest Over $55 Billion in U.S. in Next Four Years Yahoo Finance
X2 weeks Johnson & Johnson plans $55 billion in US investments over the next four years Yahoo Finance
X2 weeks JNJ’s Nipocalimab Gets FDA’s Fast Track Tag for Sjogren’s Disease Zacks
X2 weeks The Zacks Analyst Blog Highlights Visa, Johnson & Johnson, Thermo Fisher and AMREP Zacks
X2 weeks Top Stock Reports for Visa, Johnson & Johnson & Thermo Fisher Scientific Zacks
X2 weeks Johnson & Johnson (JNJ) Rises But Trails Market: What Investors Should Know Zacks
X2 weeks Kenvue + Johnson & Johnson: I Choose To Own The Whole ‘Humpty Dumpty’ Seeking Alpha
X2 weeks An AI imaging firm says Johnson & Johnson stole its tech. Testimony began Monday. Business Insider
X2 weeks The Zacks Analyst Blog Highlights Novo Nordisk, Roche, Pfizer, Arvinas and J&J Zacks
X3 weeks How Companies Like J&J, Live Nation and Uber Are Retreating From DEI The New York Times
X3 weeks PTGX Up as J&J-Partnered Drug Meets Goal in Ulcerative Colitis Study Zacks
XThe Stock Market News
The Stock Market News is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.